News Roche cancer guru quits to lead 'off-the-shelf' T-cell R&D a... San Francisco biotech developing therapy for post-transplant blood disorder
News J&J could pay $1 billion for oncolytic virus firm BeneVir J&J follows Merck & Co, and BMS with oncolytic virus acquisition
News Novel cancer immunotherapy research lands Innovate UK fundin... New programme will leverage well-validated genetic mechanisms to promote cancer immunity.
News Novartis app could revolutionise ophthalmic clinical trials Patients will be able to participate in clinical ophthalmology trials from home thanks to a groundbreaking digital app developed by Novartis.
News Lilly and Alder showcase latest migraine drug data Lilly and Alder take on the might of Novartis and Amgen
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
